Follicle Stimulating Hormone
Approved · EMAAlso known as FOLLITROPIN, FSH, Humegon, Menopur+4 more
FOLLITROPIN, FSH, Humegon, Menopur, Pergonal, Pituitary follicle stimulating hormone, Pluset, follitropin (FSH).
Recent clinical, regulatory, research and industry developments relating to this drug.
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
Muscle-derived myostatin is a major endocrine driver of follicle-stimulating hormone synthesis.
Follicle stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulation.
Hormone Regulation in Testicular Development and Function.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Indication: Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or… Show full indicationShow less
Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle.
Contains information from the European Medicines Agency (European Medicines Agency), © EMA, reused under CC BY 4.0.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Effects of Follicle-Stimulating Hormone Injection on Flow Mediated Dilation in Healthy Males
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences2
- eLife1
- Frontiers in endocrinology1
- Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology1
- Journal of affective disorders1
- Nature communications1
- Wang Y3
- Li Z2
- Liu Y2
- Aiznkot T1
- Bai H1
- Baranowska M1
- Bernard DJ1
- Boehm U1
- Icahn School of Medicine at Mount Sinai2
- School of Medicine2
- Cedars-Sinai Medical Center1
- Centre for Immunobiology1
- Chinese Academy of Medical Sciences1
- Clinical Department of Gynecology and Obstetrics1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 7 of the same disease areas as Follicle Stimulating Hormone in the shared literature.
Studied across 6 of the same disease areas as Follicle Stimulating Hormone in the shared literature.
Studied across 5 of the same disease areas as Follicle Stimulating Hormone in the shared literature.
Studied across 5 of the same disease areas as Follicle Stimulating Hormone in the shared literature.
Studied across 5 of the same disease areas as Follicle Stimulating Hormone in the shared literature.
Studied across 3 of the same disease areas as Follicle Stimulating Hormone in the shared literature.
Studied across 3 of the same disease areas as Follicle Stimulating Hormone in the shared literature.
Studied across 2 of the same disease areas as Follicle Stimulating Hormone in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.